The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Nice one chilting!
“The new customer is a leading European supplier to companies that produce materials for the fashion and related industries. As a plant-based alternative to fossil-based polymers currently used in the production process,...”
So I would hazard a guess that our customer is a Yarn Producer, supplying yarns to textile manufacturers who are producing materials for the fashion houses. Acrylic yarns (petrochemical based) are significant market and if Itaconix are successful in getting in on that with a greener replacement ingredient well, that must be worth a few more £M on the sales ledger in a couple of years time!
Good spot AJP! Man, I was hovering over the buy button yesterday for some more, but funds went on Anglo Pacific & Reckitt Benckiser instead lol. Oh well, fair chance Reckitt are or will be using Itaconix product. But If not now, then when? They got a mention - with others - in our fundraise from 2020:
https://itaconix.com/wp-content/uploads/Itaconix-PLC-Circular-and-Notice-of-General-Meeting-June-2020.pdf
The silence is deafening! A calm before a flurry news? Something must be brewing, maybe big, maybe small, as we continue the March along the timeline to breakeven & profit in 2023. It pays sometimes to be very patient when the case is compelling.
I agree Elsol. The raw material prices of Fossil Fuel derived material inputs (eg. acrylics & plastics) will be going sky high for the likes of Unilever, Colgate-Palmolive, P&G et al. Their product managers will be tasked even more now with environmentally focussed value engineering to future proof established consumer brands. Come on, ITACONIX, get in there and help all those product managers!
SB, it certainly is wierd. Other stocks with defence exposure, Rheinmetall, BAE Systems, Chemring et al are way up. We should be too. War also leads, I would have thought, to FTC defence comms customers ramping up their spends.
Quote of the day from JS: “what we are doing is Science FACT, not science fiction.” Brilliant. If I was one of their sales guys, that would be in my pitch.
Also LONG Term, partnering with someone with a view to have IA Fermentation plants, one in Europe, one in the US... interesting!
Wow, think John must have had porridge for breakfast and then haggis for afters. Never seen him so upbeat at nit giving too much away lol. I heard they expect to hit 2022 numbers and 2023 should be really exciting. Also I think I heard the VP Sales Position had been “taken out” with a sales reorganisation - looks like it according to LinkedIn she left in Aug’21! Wasn’t there for long.
I’ve been worried about that too in the past BH but John Shaw has been ver assured on that point - it’s been asked several times - on previous presentations.
The link below also shows plenty of IA shipping into USA last month from China.
https://www.zauba.com/USA-import-itaconic-acid-data.html
AJP - I hope he’s set it up to tell us the company will 100% reach Breakeven this year and we have brought back on track that revenue growth curve - but I doubt it! If he did, we’d be straight to 20p. It’ll probably be steady as she goes. I’ve submitted my questions BUT forgot to ask How the new VP Sales Monna Manning is getting on. Maybe someone else can.
Haha, JD yes I know what you mean - BUT I’d be more worried if he adopted a different persona and told us everything was GREAT! It’s just not his style, which, admittedly, is not everyone’s cup o’ tea.
That’s my questions in. Should be interesting next week - it’s been quite a ride of late. Pushing back release of final is also not without reason, may be as simple as getting lower audit fee (outwith peak period) or there is a nice big train coming down the track loaded with (hopefully good) news lol.